Last updated on February 2018

A Study of RPL554 in Patients With Cystic Fibrosis

Brief description of study

This study evaluates two doses of RPL554 and placebo in adult patients with cystic fibrosis. All patients receive all three treatments in a randomised sequence.

Clinical Study Identifier: NCT02919995

Contact Investigators or Research Sites near you

Start Over

Andres Floto

Papworth Hospital
Cambridge, United Kingdom
  Connect »